Future Events

full calendar

ESTIV President, Dr Helena Kandarova, ERT is the recipient of the prestigious Doerenkamp-Zbinden Award 2021

The Board of Trustees of the Doerenkamp-Zbinden Foundation for Animal-free Research has chosen Dr Helena Kandárová, ERT, Senior scientists at the Centre of Experimental Medicine at Slovak Academy of Sciences, in Bratislava, Slovakia and President of ESTIV as the Doerenkamp-Zbinden Prize winner in the year 2021.

ESTIV Best Poster Award at the 11th World Congress on Alternatives and Animal Use in the Life Sciences has been granted to three excellent young scientists !

  • News

Three excellent poster presentations of early-career scientists have been selected by the WC11 ESTIV Awards committee taking into account scientific excellence, innovation and clarity of the poster presentations.

ESTIV Newsletter No. 48 – Summer

Welcome to the summer edition of the ESTIV Newsletter…

ESTIV welcomes two new corporate members!

Estiv welcomes two new corporate memebers React4life and Symrise…

ESTIV Best Poster Award at the 11th World Congress on Alternatives

ESTIV will grant Best poster award, including 500€ and 1 year (2021) free ESTIV membership, to a Ph.D. student or young scientist (≤ 35 years old) presenting her/his research work in the field of in vitro or in silico toxicology per poster as the first author during the 11th World Congress on Alternatives…..

July ESTIV-ASCCT Webinar: Bridging toxicology and research: COVID-19 initiatives

Please join us Tueday, July 21 for the next in our Joint ASCCT/ESTIV webinar series. The theme of July webinar is “Bridging toxicology and research: COVID-19 initiatives”

Learn more about ESTIV 2021 Corporate members

Our corporate members help to shape the future of innovative toxicology. We are thankfull for their ongoing support of ESTIV activities.

Modelling the pathogenesis of COVID-19 using the Adverse Outcome Pathway framework (CIAO) – online webinar

The CIAO project is helping to make sense of the enormous amount of biological information on COVID-19 by exploiting a well-established knowledge framework called Adverse Outcome Pathways (AOP).

Corporate Members

Affiliated Societies

Memorandum of Understanding